# Alignment Healthcare Delivers Strong First Quarter 2026 Results, Demonstrating Disciplined Growth and Margin Expansion
Canonical URL: https://biopharmsignal.com/news/ALHC/alignment-healthcare-delivers-strong-first-quarter-2026-results-demonstrating-disciplined-growth-and-margin-expansion
Ticker: ALHC
Company: Alignment Healthcare
Source: Alignment Healthcare
Published: 2026-04-30 20:01 EST
Original Source URL: https://ir.alignmenthealth.com
## Summary

Delivers $1.24 billion in total revenue, representing 33.3% growth year-over-year Grows Medicare Advantage membership 30.9% year-over-year to approximately 284,800 members Raises the midpoint of all guidance metrics: membership, revenue, adjusted gross profit and adjusted EBITDA ORANGE, Calif.,

## Article Body
Delivers $1.24 billion in total revenue, representing 33.3% growth year-over-year Grows Medicare Advantage membership 30.9% year-over-year to approximately 284,800 members Raises the midpoint of all guidance metrics: membership, revenue, adjusted gross profit and adjusted EBITDA ORANGE, Calif.,
## Recent Company News
- 2026-06-03 20:01 EST — [Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year](https://biopharmsignal.com/news/ALHC/alignment-healthcare-named-to-the-fortune-1000-2026-list-for-second-consecutive-year) — Source: Alignment Healthcare
- 2026-06-02 12:00 EST — [Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report](https://biopharmsignal.com/news/ALHC/alignment-healthcare-shows-how-earlier-coordinated-care-leads-to-better-health-and-fewer-emergencies-in-2025-impact-report) — Source: Alignment Healthcare
- 2026-05-18 12:00 EST — [Alignment Healthcare to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026](https://biopharmsignal.com/news/ALHC/alignment-healthcare-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-2026) — Source: Alignment Healthcare
- 2026-05-14 20:01 EST — [Alignment Health Plan Recognized as One of Four Medicare Advantage Prescription Drug Plans in the U.S. for 2026 Excellence in Quality](https://biopharmsignal.com/news/ALHC/alignment-health-plan-recognized-as-one-of-four-medicare-advantage-prescription-drug-plans-in-the-u-s-for-2026-excellence-in-quality) — Source: Alignment Healthcare
- 2026-05-12 20:30 EST — [Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation](https://biopharmsignal.com/news/ALHC/alignment-healthcare-strengthens-leadership-team-to-support-long-term-growth-and-shareholder-value-creation) — Source: Alignment Healthcare
## Related News
- 2026-07-22 20:15 EST — BFRG — [BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-the-btig-virtual-biotechnology-conference-5880a10e)
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
- 2026-07-22 20:01 EST — AXON — [Axon to Release Second Quarter 2026 Earnings on August 5, 2026](https://biopharmsignal.com/news/AXON/axon-to-release-second-quarter-2026-earnings-on-august-5-2026-66120902)
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)